BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 38596494)

  • 1. Stage at diagnosis of colorectal cancer through diagnostic route: Who should be screened?
    Agatsuma N; Utsumi T; Nishikawa Y; Horimatsu T; Seta T; Yamashita Y; Tanaka Y; Inoue T; Nakanishi Y; Shimizu T; Ohno M; Fukushima A; Nakayama T; Seno H
    World J Gastroenterol; 2024 Mar; 30(10):1368-1376. PubMed ID: 38596494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening for Colorectal Cancer Is Associated With Lower Disease Stage: A Population-Based Study.
    Kubisch CH; Crispin A; Mansmann U; Göke B; Kolligs FT
    Clin Gastroenterol Hepatol; 2016 Nov; 14(11):1612-1618.e3. PubMed ID: 27085763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical effectiveness of different surveillance strategies to prevent colorectal cancer in people with intermediate-grade colorectal adenomas: a retrospective cohort analysis, and psychological and economic evaluations.
    Atkin W; Brenner A; Martin J; Wooldrage K; Shah U; Lucas F; Greliak P; Pack K; Kralj-Hans I; Thomson A; Perera S; Wood J; Miles A; Wardle J; Kearns B; Tappenden P; Myles J; Veitch A; Duffy SW
    Health Technol Assess; 2017 Apr; 21(25):1-536. PubMed ID: 28621643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interval Colorectal Cancer Incidence Among Subjects Undergoing Multiple Rounds of Fecal Immunochemical Testing.
    van der Vlugt M; Grobbee EJ; Bossuyt PMM; Bos A; Bongers E; Spijker W; Kuipers EJ; Lansdorp-Vogelaar I; Spaander MCW; Dekker E
    Gastroenterology; 2017 Aug; 153(2):439-447.e2. PubMed ID: 28483499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of a colorectal cancer screening program implantation on delays and prognosis of non-screening detected colorectal cancer.
    Cubiella J; Lorenzo M; Baiocchi F; Tejido C; Conde A; Sande-Meijide M; Castro M
    World J Gastroenterol; 2021 Oct; 27(39):6689-6700. PubMed ID: 34754161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New trend in colorectal cancer in Germany: are young patients at increased risk for advanced colorectal cancer?
    Ambe PC; Jansen S; Zirngibl H
    World J Surg Oncol; 2017 Aug; 15(1):159. PubMed ID: 28835275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of missed or interval colorectal cancer and patient survival: a population-based study.
    Samadder NJ; Curtin K; Tuohy TM; Pappas L; Boucher K; Provenzale D; Rowe KG; Mineau GP; Smith K; Pimentel R; Kirchhoff AC; Burt RW
    Gastroenterology; 2014 Apr; 146(4):950-60. PubMed ID: 24417818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colorectal cancer incidence, mortality, tumour characteristics, and treatment before and after introduction of the faecal immunochemical testing-based screening programme in the Netherlands: a population-based study.
    Breekveldt ECH; Lansdorp-Vogelaar I; Toes-Zoutendijk E; Spaander MCW; van Vuuren AJ; van Kemenade FJ; Ramakers CRB; Dekker E; Nagtegaal ID; Krul MF; Kok NFM; Kuhlmann KFD; Vink GR; van Leerdam ME; Elferink MAG;
    Lancet Gastroenterol Hepatol; 2022 Jan; 7(1):60-68. PubMed ID: 34822762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Equivalency of fecal immunochemical tests and colonoscopy in familial colorectal cancer screening.
    Quintero E; Carrillo M; Gimeno-García AZ; Hernández-Guerra M; Nicolás-Pérez D; Alonso-Abreu I; Díez-Fuentes ML; Abraira V
    Gastroenterology; 2014 Nov; 147(5):1021-30.e1; quiz e16-7. PubMed ID: 25127679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival of patients with symptom- and screening-detected colorectal cancer.
    Brenner H; Jansen L; Ulrich A; Chang-Claude J; Hoffmeister M
    Oncotarget; 2016 Jul; 7(28):44695-44704. PubMed ID: 27213584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced risk of colorectal cancer up to 10 years after screening, surveillance, or diagnostic colonoscopy.
    Brenner H; Chang-Claude J; Jansen L; Knebel P; Stock C; Hoffmeister M
    Gastroenterology; 2014 Mar; 146(3):709-17. PubMed ID: 24012982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Time to Colonoscopy and Risk of Colorectal Cancer in Patients With Positive Results From Fecal Immunochemical Tests.
    Lee YC; Fann JC; Chiang TH; Chuang SL; Chen SL; Chiu HM; Yen AM; Chiu SY; Hsu CY; Hsu WF; Wu MS; Chen HH
    Clin Gastroenterol Hepatol; 2019 Jun; 17(7):1332-1340.e3. PubMed ID: 30391435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Time Trends in the Diagnosis of Colorectal Cancer With Obstruction, Perforation, and Emergency Admission After the Introduction of Population-Based Organized Screening.
    Decker KM; Lambert P; Nugent Z; Biswanger N; Samadder J; Singh H
    JAMA Netw Open; 2020 May; 3(5):e205741. PubMed ID: 32453385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. No decrease in the rate of early or missed colorectal cancers after colonoscopy with polypectomy over a 10-year period: a population-based analysis.
    Pullens HJ; Leenders M; Schipper ME; van Oijen MG; Siersema PD
    Clin Gastroenterol Hepatol; 2015 Jan; 13(1):140-7. PubMed ID: 24815328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening colonoscopy and risk for incident late-stage colorectal cancer diagnosis in average-risk adults: a nested case-control study.
    Doubeni CA; Weinmann S; Adams K; Kamineni A; Buist DS; Ash AS; Rutter CM; Doria-Rose VP; Corley DA; Greenlee RT; Chubak J; Williams A; Kroll-Desrosiers AR; Johnson E; Webster J; Richert-Boe K; Levin TR; Fletcher RH; Weiss NS
    Ann Intern Med; 2013 Mar; 158(5 Pt 1):312-20. PubMed ID: 23460054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of the faecal immunochemical test on colorectal cancer survival.
    Gutierrez-Stampa MA; Aguilar V; Sarasqueta C; Cubiella J; Portillo I; Bujanda L
    BMC Cancer; 2020 Jul; 20(1):616. PubMed ID: 32611328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk Factors for Diagnosis of Colorectal Cancer at a Late Stage: a Population-Based Study.
    Andrew AS; Parker S; Anderson JC; Rees JR; Robinson C; Riddle B; Butterly LF
    J Gen Intern Med; 2018 Dec; 33(12):2100-2105. PubMed ID: 30284171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fecal occult blood test for colorectal cancer screening: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2009; 9(10):1-40. PubMed ID: 23074514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current screening guidelines overlook a significant number of patients treated for colorectal cancer.
    Przybyla AG; Crockett JA; Rex JC; Culumovic PJ
    Am Surg; 2014 Jun; 80(6):539-43. PubMed ID: 24887789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics and survival of interval and sporadic colorectal cancer patients: a nationwide population-based cohort study.
    Erichsen R; Baron JA; Stoffel EM; Laurberg S; Sandler RS; Sørensen HT
    Am J Gastroenterol; 2013 Aug; 108(8):1332-40. PubMed ID: 23774154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.